(Q114686061)
Statements
Contract Drug Manufacturer Catalent to Buy Paragon Bioservices in $1.2 Billion Deal (English)
0 references
14 April 2019
0 references
464
0 references
Wall Street Journal article (April 14, 2019)
No description defined